SCHEMBL6168411

SCHEMBL6168411

O=C(c1ccc(Cl)cc1)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.82
KMT2A Q03164 4/20 0.82
NPC1 O15118 2/20 0.82
RAB9A P51151 2/20 0.82
F7 P08709 1/20 0.68
F3 P13726 1/20 0.68
FLT3 P36888 3/20 0.62
NHERF1 O14745 1/20 0.58
HRH4 Q9H3N8 4/20 0.55
HRH3 Q9Y5N1 2/20 0.55
PDGFRB P09619 2/20 0.55
ABL1 P00519 1/20 0.53
KIT P10721 1/20 0.53
BCR P11274 1/20 0.53
HRH1 P35367 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
SMYD3 Q9H7B4 1/20 0.52
CLK1 P49759 1/20 0.51
DYRK1A Q13627 1/20 0.51
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168943 0.88 MEN1 (0.65) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6169285 0.88 RAB9A (0.65) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6170035 0.87 MEN1 (0.63) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6170838 0.86 MEN1 (0.81) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6168456 0.85 MEN1 (0.70) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL17927587 0.84 NPC1 (0.64) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6389802 0.84 FLT3 (0.80) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6405713 0.81 MAPT (0.70) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6172296 0.81 MEN1 (0.72) MEN1KMT2ANPC1RAB9AF7
SCHEMBL2694131 0.81 F7 (0.74) MEN1KMT2ANPC1RAB9AF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed